Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus

Immunology

Volumn 126, Issue 1, 2009, Pages 140-146

  Schepis, Danika ^a,b   Gunnarsson, Iva ^b   Eloranta, Maija Leena ^c   Lampa, Jon ^b   Jacobson, Stefan H ^d   Kärre, Klas ^a   Berg, Louise ^a  

^a IRI   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d DANDERYD HOSPITAL   (Sweden)

Author keywords

CD56bright natural killer cell; Natural killer cells; Systemic lupus erythematosus; Type I interferon

Indexed keywords

ALPHA INTERFERON; CD56 ANTIGEN; CD69 ANTIGEN; CD94 ANTIGEN; INTERFERON; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR LIR; NATURAL KILLER CELL RECEPTOR NKG2C; NATURAL KILLER CELL RECEPTOR NKG2D; NATURAL KILLER CELL RECEPTOR NKP30; NATURAL KILLER CELL RECEPTOR NKP44; NK CELL ACTIVATING RECEPTOR NKP46; UNCLASSIFIED DRUG; CYTOKINE;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD56 BRIGHT NATURAL KILLER CELL; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A NEPHRITIS; IN VITRO STUDY; LYMPHOCYTE; NATURAL KILLER CELL; NEPHRITIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; CELL CULTURE; IMMUNOLOGY; MALE; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD56; AUTOIMMUNE DISEASES; CELLS, CULTURED; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE I; INTERFERON-ALPHA; KILLER CELLS, NATURAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 57449089601     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02887.x     Document Type: Article

References (32)

1. Rönnblom L, Eloranta ML, Alm GV. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum 2006 54 : 408 20.
2. Vallin H, Perers A, Alm GV, Rönnblom L. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J Immunol 1999 163 : 6306 13.
3. Barrat FJ, Meeker T, Gregorio J et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 2005 202 : 1131 9.
4. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol 2004 22 : 405 29.
5. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004 5 : 1260 5.
6. + B cells. J Immunol 2001 167 : 6132 9.
7. Gao N, Dang T, Yuan D. IFN-gamma-dependent and -independent initiation of switch recombination by NK cells. J Immunol 2001 167 : 2011 8.
8. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982 25 : 1271 7.
9. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988 31 : 315 24.
10. Vallin H, Blomberg S, Alm GV, Cederblad B, Rönnblom L. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin Exp Immunol 1999 115 : 196 202.
11. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001 97 : 3146 51.
12. Li Z, Lim WK, Mahesh SP, Liu B, Nussenblatt RB. Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis. J Immunol 2005 174 : 5187 91.
13. Bielekova B, Catalfamo M, Reichert-Scrivner S et al. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci U S A 2006 103 : 5941 6.
14. bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta. Neurol Sci 2007 28 : 121 6.
15. Titanji K, Sammicheli S, De Milito A et al. Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection. Immunology 2008 123 : 164 70.
16. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001 166 : 6477 82.
17. dim cells: role of contact with peripheral fibroblasts. J Immunol 2007 179 : 89 94.
18. dim NK cells upon activation. J Immunol 2007 178 : 4947 55.
19. bright natural killer cells. Immunity 2005 22 : 295 304.
20. bright subset of NK cells is resistant to oxidant-induced cell death. J Immunol 2007 179 : 781 5.
21. + CD56(dim) subset. J Immunol 2007 179 : 4513 9.
22. Johansson S, Berg L, Hall H, Hoglund P. NK cells: elusive players in autoimmunity. Trends Immunol 2005 26 : 613 8.
23. Erkeller-Yusel F, Hulstaart F, Hannet I, Isenberg D, Lydyard P. Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus. Lupus 1993 2 : 227 31.
24. Pan LZ, Dauphinee MJ, Ansar Ahmed S, Talal N. Altered natural killer and natural cytotoxic cellular activities in lpr mice. Scand J Immunol 1986 23 : 415 23.
25. Toyabe S, Kaneko U, Uchiyama M. Decreased DAP12 expression in natural killer lymphocytes from patients with systemic lupus erythematosus is associated with increased transcript mutations. J Autoimmun 2004 23 : 371 8.
26. Takeda K, Dennert G. The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J Exp Med 1993 177 : 155 64.
27. Shi FD, Wang HB, Li H, Hong S, Taniguchi M, Link H, Van Kaer L, Ljunggren HG. Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat Immunol 2000 1 : 245 51.
28. Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science (New York, NY) 1982 216 : 429 31.
29. Zhuang H, Kosboth M, Lee P et al. Lupus-like disease and high interferon levels corresponding to trisomy of the type I interferon cluster on chromosome 9p. Arthritis Rheum 2006 54 : 1573 9.
30. Santiago-Raber ML, Baccala R, Haraldsson KM, Choubey D, Stewart TA, Kono DH, Theofilopoulos AN. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 2003 197 : 777 88.
31. Rönnblom LE, Alm GV, Oberg K. Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment. Acta Oncol (Stockholm, Sweden) 1991 30 : 537 40.
32. von Wussow P, Jakschies D, Hochkeppel H, Horisberger M, Hartung K, Deicher H. MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1989 32 : 914 8.